New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2013
09:54 EDTWAL, OMPI, ENPH, APOL, SYT, IR, CLF, SNBC, FMCN, CRLOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Apollo Group (APOL) downgraded to Market Perform from Outperform at Wells Fargo... Charles River Labs (CRL) downgraded to Market Perform from Outperform at Wells Fargo... Cliffs Natural (CLF) downgraded to Underweight from Equal Weight at Morgan Stanley... Enphase Energy (ENPH) downgraded to Underperform from Market Perform at Raymond James... Focus Media (FMCN) downgraded to Underperform from Buy at CLSA... Ingersoll-Rand (IR) downgraded to Neutral from Overweight at JPMorgan... Obagi Medical (OMPI) downgraded to Neutral from Buy at Roth Capital... Sun Bancorp (SNBC) downgraded to Underperform from Neutral at Sterne Agee... Syngenta (SYT) downgraded to Neutral from Overweight at HSBC... Western Alliance (WAL) downgraded to Market Perform from Outperform at Keefe.
News For APOL;CRL;CLF;ENPH;FMCN;IR;OMPI;SNBC;SYT;WAL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
June 30, 2015
08:17 EDTAPOLApollo Education price target lowered to $20 from $29 at BMO Capital
BMO Capital cut its price target on Apollo after the company reported higher than expected Q3 EPS but lowered its fiscal 2015 guidance. The firm says that the company's Q3 enrollment and revenue were "subpar," and it thinks the company will continue to shrink. However, BMO adds that it still believes that "the stock is worth looking at on a sum of the parts basis." It keeps an Outperform rating on the shares.
June 29, 2015
19:01 EDTAPOLOn The Fly: After Hours Movers
HIGHER: Juno Therapeutics (JUNO), up 38.4% after announcing immunotherapy collaboration with Celgene (CELG)... Kite Pharma (KITE) and Lion Biotechnologies (LBIO) are up 8.7% and 5.7% respectively, following Juno's collaboration with Celgene. DOWN AFTER EARNINGS: CHC Group (HELI), down 8%... Apollo Education (APOL), down 6.2%. ALSO LOWER: EnteroMedics (ETRM), down 12.4% after filing to sell common stock and warrants... Celgene (CELG), down 1% after Juno announces immunotherapy collaboration.
17:52 EDTAPOLApollo Education sees FY16 student enrollment about 150,000 students
Subscribe for More Information
16:12 EDTAPOLApollo Education revises FY15 revenue view to $2.6B-$2.62B, consensus $2.63B
Subscribe for More Information
16:10 EDTAPOLApollo Education reports Q3 EPS 53c ex-items, consensus 47c
Subscribe for More Information
15:23 EDTAPOLNotable companies reporting after market close
Subscribe for More Information
13:27 EDTAPOLApollo Education technical notes ahead of earnings
The stock is trading close to its 52-week lows ahead of results, in a strongly bearish downtrend. If the news continues to be as bearish or more bearish than current expectations, there could be more downside to come. Support levels to watch below the current price of $15.73 would be at $14.42, $13.50, and $12.50. If the news is a bullish surprise, upside would be at $16.78, $17.54, and $18.36.
07:59 EDTAPOLApollo Education post-earnings rally could be brief, WSJ says
Subscribe for More Information
07:34 EDTAPOLApollo Education July volatility elevated into Q3 and outlook
Subscribe for More Information
June 24, 2015
16:21 EDTSYTOn The Fly: Top stock stories for Wednesday
Subscribe for More Information
14:57 EDTAPOLApollo Education July volatility elevated into Q3 and outlook
Apollo Education July call option implied volatility is at 68. August is at 49; compared to its 52-week range of 27 to 67, suggesting large July price movement into the expected release of Q3 results on June 29.
10:16 EDTSYTMonsanto CEO says 'probably haven't been around first lap' with Syngenta
Monsanto (MON) CEO says the company is "keeping its powder dry" while it strives to strike a deal with Syngenta (SYT), but would revert to its prior capital commitments and possibly seek other opportunities if one cannot be reached.
09:46 EDTSYTMonsanto CEO says interest in Syngenta seeds unit 'extraordinary'
09:41 EDTSYTMonsanto CEO says Syngenta overstates risks of deal
Subscribe for More Information
08:09 EDTSYTMonsanto: Proposal to combine with Syngenta 'logical next step' for business
June 23, 2015
16:29 EDTSYTOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
13:56 EDTSYTSyngenta chairman says Monsanto offer insufficient, Finanz und Wirtschaft says
Syngenta (SYT) chairman Michel Demare confirmed his company's rejection of Monsanto's (MON) offer as the current terms are "unacceptable," Demare said in an interview with Finanz und Wirtschaft, and added that while the current offer is "insufficient," there is a willingness to negotiate. Reference Link
10:31 EDTSYTMonsanto says Bayer crop chemicals unit an option, Bloomberg reports
Subscribe for More Information
06:42 EDTSYTMonsanto CEO: company not deterred by Syngenta rejections, WSJ reports
Subscribe for More Information
05:28 EDTSYTSyngenta chairman reaffirms position regarding Monsanto proposal
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use